
You might’ve seen the news recently, the fair trade regulator CCI has given its nod to a joint proposal by 360 ONE and Claypond Capital Partners to acquire stakes in API Holdings, the parent company of PharmEasy. This development has once again put API Holdings in the spotlight, especially in the unlisted shares market, where many are already tracking its financials and performance closely.
If you're curious about the company’s current share price or wondering how its unlisted shares work, you're in the right place. In this blog, you'll find everything you need to know, from what API Holdings does to the current API Holdings share price and a quick look at its financial performance.
You’ll also learn how to buy and sell API Holdings unlisted shares, with easy steps tailored for the Indian market. Whether you're following the company for insights or just trying to understand how unlisted shares function.
Let’s explore!
Fino Paytech Limited is a fintech company focused on digital banking and financial inclusion in India.
You can buy or sell Fino Paytech unlisted shares through trusted platforms like Precize, which offers a smooth and verified transaction process.
The current unlisted share price is updated regularly on platforms like Precize.
API Holdings is one of India’s largest digital healthcare platforms and the parent company of brands like PharmEasy, Thyrocare, Retailio, Aknamed, and Docon. While PharmEasy is widely known as an online pharmacy, API Holdings operates a much broader network of healthcare services.
Founded in 2019 and based in Mumbai, the company uses technology to connect people with essential healthcare solutions. Through its platforms, users can buy medicines, book diagnostic tests, and consult doctors online.
Each brand serves a specific purpose:
PharmEasy – online medicine delivery.
Thyrocare – diagnostic testing.
Retailio – wholesale medicine distribution.
Aknamed – hospital supply chain management.
Docon – digital tools for doctors and clinics.
API Holdings brings all these services together to support various parts of the healthcare journey. With its own tech systems and supply chain, the company focuses on making healthcare more accessible and organized across India.
Before going deeper into its financials and buying process, here’s the latest update on its unlisted share price.
As of 17 July 2025, the API Holdings share price in the unlisted market is approximately ₹7.00 per share. The face value of each share is ₹1.00. If you're looking to buy in lots, the price per lot (which typically includes 1,429 shares) comes to around ₹10,003.00.
Please note that unlisted share prices may vary slightly depending on the platform or dealer, and they are not traded on regular stock exchanges.
[The information provided here is for general awareness. Share prices in the unlisted market can change and may vary across sources. Always verify the latest price from a trusted platform before making any decisions.]
[Source: Financial Reports]
To understand what’s behind the numbers, it helps to look at the company’s financial performance.
The following are the key financial figures of API Holdings for FY 2024:
[Source: Financial Reports]
With the numbers offering a glimpse into the company’s growth, the next question is whether it aligns with emerging market opportunities.
API Holdings is gaining momentum in India’s fast-evolving digital healthcare landscape. If you're exploring opportunities in the unlisted space, here are a few key points to consider:
Strong Digital Backbone: With PharmEasy as a flagship brand, API Holdings continues to expand its digital healthcare reach.
High Relevance Post-Pandemic: The shift toward online healthcare solutions has made companies like API Holdings more essential than ever.
Potential for Future Growth: The company’s position in a high-demand sector indicates long-term business expansion possibilities.
Pre-Listing Opportunity: Tracking API Holdings in the unlisted space allows early exposure before any public market entry.
Easy Access via Trusted Platforms: Platforms like Preciize offer verified access to unlisted shares, along with regular updates and support.
To truly evaluate the opportunity, let's take a closer look at what makes API Holdings stand out.
There are several reasons why API Holdings is attracting attention from private investors:
Trusted Brand Portfolio: PharmEasy is already a recognized name in India’s online pharmacy space, which strengthens the credibility of API Holdings.
Multiple Revenue Streams: Beyond pharmacy services, the company has expanded into diagnostics, wellness, and telehealth services, adding stability and growth potential.
IPO Buzz: There’s increasing speculation about a future IPO. This keeps the API Holdings unlisted share price in focus for investors seeking opportunities before listing.
Sector Boom: India’s digital healthcare sector is seeing fast-paced growth. API Holdings is well-placed to benefit from this upward trend.
Now that the growth potential is clearer, the next logical step is understanding how to access API Holdings in the unlisted space.

Buying API Holdings unlisted shares can be done smoothly through a trusted platform like Precize, which offers access to shares of leading private companies in India. Here are some simplified pointers to help you get started:
Select a Platform

Begin by visiting a reliable investment platform such as Precize, known for its secure handling of unlisted shares. It provides verified opportunities and a user-friendly experience.
Register and Set Up Your Profile
Create your account by entering your email, mobile number, and setting a password. Once registered, complete your profile by adding your PAN card, bank account, and Demat account details (NSDL or CDSL).
Search for API Holdings
After setup, use the platform’s search option to find API Holdings. You’ll be able to view the current share price, company details, and lot size.
Decide Quantity and Check Minimum Investment
Choose the number of shares or lots you'd like to buy. Most platforms, including Precize, require a minimum investment amount of ₹10,000.
Add Funds and Place Your Order
Transfer funds to your wallet using UPI or net banking. Once your account is funded, confirm and place your order.
Share Transfer to Demat Account
After the order is processed (usually within 24–48 business hours), the shares are transferred to your Demat account. You’ll receive confirmation through email or WhatsApp.
Let’s move from buying to the next important step, selling your unlisted shares when the time is right.
If you hold API Holdings unlisted shares and want to sell them, the process is simple, especially if the shares were bought through a trusted platform like Precize. Here's how it works:
First, you’ll need to transfer the shares from your Demat account to the platform. Once the shares are received, usually within 24 to 48 business hours, Precize will begin the process of finding a buyer at the current market price.
After a buyer is matched, the sale is completed, and the payment is credited directly to your registered bank account. This process typically takes another 24 to 48 business hours after the share transfer.
It’s important to note that this quick resale option is generally available only for shares purchased through Precize, as the platform maintains verified buyer and seller networks.
Tracking the API Holdings share price gives you a better understanding of one of India’s leading digital healthcare companies. While the company holds strong potential through brands like PharmEasy and Thyrocare, its current financials reflect that it’s still in a growth phase. One of the pros of investing in such companies is early access to high-potential businesses before they go public. However, the cons include limited liquidity and higher risk due to the unlisted nature of the shares.
If you're looking to explore unlisted shares like API Holdings, Precize makes the process easy and transparent. It allows you to buy and sell unlisted and pre-IPO shares of top private companies and even explore global trade finance opportunities to diversify your portfolio with fixed-income options.
Want to explore opportunities like this? Reserve access on Precize today and get started with a diversified portfolio!
Yes, PharmEasy is one of the key brands owned and operated by API Holdings. API Holdings Limited is India’s largest digital healthcare platform and serves as the parent company behind the PharmEasy app, along with several other healthcare-focused businesses. If you hold shares in API Holdings, you indirectly have a stake in PharmEasy’s operations.
If you want to sell your API Holdings shares before its IPO, the process can be done smoothly through trusted platforms that deal in unlisted shares like Precize.
The information provided above is for general awareness only and should not be considered as financial advice or a recommendation to buy or sell any unlisted securities. Share transactions in the unlisted market involve risks and should always be done through verified platforms or registered intermediaries. Please do your own research or consult with a financial advisor before making any decisions.

Join our newsletter for exclusive access to thoughtfully curated content and we promise, no spam
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved